PEPhilipp Eberwein

Philipp Eberwein

*This is an algorithmically generated author record based on publicly available information.

Philipp Eberwein has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Long-term follow-up after scleral lens fixation in patients with Marfan syndrome

    by Jan Luebke, Thomas Reinhard, Hansjuergen Agostini, Daniel Boehringer, Philipp Eberwein

    The dislocation of the crystalline lens is a common finding in patients with Marfan syndrome (MFS). Scleral intraocular lens (IOL) fixation is an accepted treatment method of this complication. To now, no long-term data on scleral IOL fixation in MFS exist. We present a retrospective study of 27 eyes of 17 MFS patients that underwent scleral lens fixation at our clinic between 1999 and 2012. These patients are compared to an age- and surgeon-matched group of 31 eyes of 27 patients who underwent the same procedure for reasons other than MFS. The median age in the MFS group was 35.4 years versus 35.6 years in the non-MFS group. The median follow-up was 4 years for MFS and 3 years for non-MFS. In the MFS group, significantly more IOL-dislocations occurred than compared to the non-MFS group (30% vs. 6.5%, p = 0.02). Retinal detachment occurred in four MFS-eyes compared to three eyes in the non-MFS group. Biometry prediction error was 1.11 diopters (D) for MFS and 1.33 D for non-MFS (p = 0.11). Median BCVA (best-corrected visual acuity, logMAR) was 0.1 in the MFS group versus 0.3 in non-MFS patients. Scleral lens fixation in MFS patients achieves satisfying visual and refractive outcomes. Our data shows a significantly higher rate of IOL dislocations in patients with MFS. We therefore recommend addressing this complication preoperatively.


  • Corneal K-Values as a Diagnostic Screening Tool for Marfan Syndrome

    by Jan Luebke, Daniel Boehringer, Philipp Eberwein, Thomas Reinhard

    Marfan syndrome (MFS) is diagnosed based on Ghent nosology, including major and minor criteria such as increased axial length (AXL) and flattened corneal curvature (higher K-values) or myopia of more than -3 diopters (D) in its latest revision. Because corneal flattening may, in part, be caused by AXL increase, it may be helpful to consider K-values separately. We present statistical evaluation of using corneal K-values for identifying MFS. A retrospective study of K-values of 74 right eyes of 74 patients with MFS, who were compared with an age- and AXL-matched group of 74 right eyes of 74 patients without MFS. After multivariate analysis, receiver operating characteristic curves were calculated. Mean age was 44.1 years versus 44.9 years (P = 0.834). Mean AXL was 25.22 mm versus 25.47 mm (P = 0.661). K-values showed significant differences: mean Kmax was 8.25 mm (40.91 D) versus 7.9 mm (42.72 D) (P < 0.001) and mean Kmin was 8.22 mm (41.06 D) versus 7.69 mm (43.89 D) (P < 0.001). The area under the curve in receiver operating characteristic analysis was 0.82 for Kmax and 0.78 for Kmin; the best cutoff was seen at a Kmax of at least 8.16 mm (41.36 D; sensitivity 73% and specificity 81%). Although both K-values differ significantly, Kmax is the better marker to identify MFS. A Kmax of more than 8.16 mm (41.36 D) seems to be a reasonable cutoff (specificity of 81% and sensitivity of 73%). Because this biometric value is easily obtained and standardized, we see it as a good supporting screening tool for MFS suspects.


  • Long‐term follow‐up of astigmatic keratotomy for corneal astigmatism after penetrating keratoplasty

    by Daniel Böhringer, Nina Dineva, Philip Maier, Florian Birnbaum, Thomas Kirschkamp, Thomas Reinhard, Philipp Eberwein

    Purpose: To report the long‐term stability of paired arcuate corneal keratotomies (AKs) in patients with high regular postpenetrating keratoplasty astigmatism.Methods: Retrospective chart review of best‐corrected visual acuity, refraction and keratometric values of 41 eyes with AK between 2003 and 2012.Results: Magnitude of median target induced astigmatism vector was 9.2 dioptres (Dpt). We reached a median magnitude of surgically induced astigmatism vector of 9.81 Dpt and a median magnitude of difference vector of 5.5 Dpt. In keratometry, we achieved a net median astigmatism reduction by 3.3 Dpt. The average correction index was 1.14, showing a slight overcorrection. Irregularity of keratometric astigmatism increased by 0.6 Dpt, and spherical equivalent changed by 1.75 Dpt. Monocular best spectacle corrected visual acuity increased from preoperatively 20/63 (0.5 logMAR) to 20/40 (0.3 logMAR) postoperatively. Median gain on the ETDRS chart was two lines. Long‐term follow‐up showed a median keratometric astigmatic increase by 0.3 Dpt per year.Conclusion: Arcuate corneal keratotomies is a safe and effective method to reduce high regular corneal astigmatism following penetrating keratoplasty but has limited predictability. The long‐term follow‐up shows an increase of keratometric astigmatism by 0.3 Dpt/year, equalizing the surgical effect after 10 years.


  • Concise Reviews: The Role of Biomechanics in the Limbal Stem Cell Niche: New Insights for Our Understanding of This Structure

    by Philipp Eberwein, Thomas Reinhard

    The limbal stem cell niche is a structure of the ocular surface that is characterized by high specification, organization, and clinical significance. Harboring the limbal epithelial stem cells, which are the progenitor cells of the corneal epithelium, it provides a niche environment that guarantees the self-renewal of the corneal epithelial stem cells throughout life. Growth factors, stromal niche cells, and specific extracellular matrix compositions provide this environment. In recent years, another important component has been added to this list: the biomechanical aspect of the niche. This review focuses on this new and still underestimated aspect, which exhibits a direct effect on cells and can also influence growth and differentiation. Stem Cells 2015;33:916–924


    • 19 July 2013
      • Vol. 19, 1492-1501
    Open Access

    Conjunctival HLA-DR and CD8 expression detected by impression cytology in ocular graft versus host disease

    by Philipp Eberwein, Susanne Issleib, Daniel Böhringer, Hans Mittelviefhaus, Johannes Schwartzkopff, Juergen Finke, Thomas Reinhard

    To assess the expression of human leucocyte antigen (HLA)-DR in epithelial cells and cluster of differentiation (CD8)-positive lymphocytes as possible markers of chronic ocular graft versus host disease (cGvHD) after hematological stem cell transplantation (HSCT). Twenty-seven consecutive patients with dry-eye symptoms following HSCT (24 [89%] with peripheral blood stem cell transplantation and 3 [11%] with bone marrow transplants; 17 [63%] familiar allogenic grafts) and 19 age-matched controls were included. Conjunctival impression cytology specimens were stained for HLA-DR, cytokeratin 19, and CD8. Oxford grading scale, blinking frequency, Schirmer test, tear film break-up time (TBUT), and Ocular Surface Disease Index (OSDI) were also recorded. Wilcoxon nonparametric testing was used to compare controls and HSCT recipients and to assess HSCT recipient subgroups with and without clinical cGVHD. Eighteen patients showed clinical signs of ocular cGVHD. TBUT and Schirmer test scores were significantly lower in patients, while Oxford grades and OSDI were significantly higher than in controls. Epithelial HLA-DR expression was generally higher in HSCT recipients than in controls, but it did not correlate with ocular cGVHD status. CD8-positive lymphocytes were identified in five patients with ocular cGvHD and one control. A strong HLA-DR expression as detected by impression cytology appears to indicate a general HSCT response and fails to predict ocular cGVHD. However, the detection of CD8-positive lymphocytes using impression cytology was frequently associated with ocular cGvHD. Our data warrant further evaluation of CD8 expression in impression cytology, along with comparison to conjunctival biopsies and brush cytology, as impression cytology may offer a less invasive strategy for assessing cGVHD status.


  • Aktuelle und zukünftige Therapieoptionen bei Erkrankungen der Limbusstammzellen

    by P. Eberwein, T. Reinhard

    Die Limbusstammzelltransplantation stellt eine der größten Herausforderungen in der chirurgischen Therapie von Augenoberflächenerkrankungen dar. Während Patienten mit einseitiger oder partieller Limbusstammzellinsuffizienz (LSI) mit autologen lamellären Limbustransplantaten vom Partnerauge versorgt werden, kann bei fortgeschrittener beidseitiger, aber noch partieller LSI eine Ex-vivo-Expansion autologer Limbusstammzellen auf Amnionmembran durchgeführt werden. Diese Technik wurde in den letzten Jahren im Bereich der Substrate, auf denen die Zellen wachsen, weiterentwickelt. Dagegen kann die beidseitige komplette LSI nur durch Transplantation allogenen Limbusgewebes behandelt werden, was immunologische Risiken birgt, jedoch durch den Einsatz von Mitomycin C und Amnionmembran verbessert werden konnte. Ob dieses Verfahren in Zukunft durch die Transplantation ex vivo expandierter oraler Mukosa als Ersatz des kornealen Epithels abgelöst wird, müssen zukünftige Studien noch klären. Während rein experimentelle Ansätze zur Transdifferenzierung von Knochenmarksstammzellen zu epithelialen Zellen als nicht durchführbar verworfen wurden, könnte die Verwendung von transdifferenzierten Haarfollikelstammzellen als Ersatz für korneales Epithel vielversprechender sein. Diese Versuche reichen aktuell jedoch noch nicht über das In-vitro-Stadium hinaus. Therapy for limbal stem cell insufficiency (LSCI) is one of the most challenging tasks in ocular surface surgery. Partial and unilateral LSCI can be treated by fractionated abrasion or autologous limbal stem cell transplantation from the fellow eye. In cases of advanced bilateral and partial LSCI, transplantation of ex vivo expanded sheets of limbal stem cells on amniotic membrane or fibrin may be performed. All patients with complete bilateral LSCI must rely on allogenic limbal stem cell transplantation comprising higher immunological risks. Progress using this technique has been achieved by the application of mitomycin C and amniotic membrane. Alternatively, transplantation of ex vivo expanded oral mucosal sheets may be used in bilateral LSCI, but only few long-term data are available on this technique as yet. While experimental attempts to use transdifferentiated bone marrow stem cells as a substitute for corneal epithelial cells have been without success, transdifferentiation of hair follicle stem cells to corneal epithelial cells may be more promising due to the identical lineage. But these experiments have not gone beyond the in vitro stage yet.


  • Oberflächenrekonstruktion bei Limbusstammzellinsuffizienz

    by P. Eberwein, T. Reinhard

    Reconstruction of the ocular surface in patients with limbal stem cell insufficiency (LSI) remains one of the most challenging tasks in ophthalmology. The transplantation of lamellar limbal tissue in total LSI represents an established therapeutic concept, while an abrasion of the conjunctival pannus allowing normal limbal epithelium to recolonize the cornea is the treatment of choice in partial LSI. Surgery must be postponed until an inflammation-free period is reached and lid abnormalities have been corrected. In unilateral total LSI autologous limbal tissue from the healthy eye is transplanted in order to circumvent immunological adverse events. In bilateral total LSI cadaveric or living related allogenic limbal tissue is used for transplantation, in which case systemic immunosuppression and HLA matching are mandatory. The combination with amniotic membrane transplantation and mitomycin C treatment can further improve long-term outcome of limbal stem cell transplantation.


  • Allogenic Limbo-keratoplasty with Conjunctivoplasty, Mitomycin C, and Amniotic Membrane for Bilateral Limbal Stem Cell Deficiency

    by Philipp Eberwein, Daniel Böhringer, Johannes Schwartzkopff, Florian Birnbaum, Thomas Reinhard


  • Perspektiven und aktueller Stand der Limbusstammzelltransplantation

    by P. Eberwein, T. Reinhard

    Die Limbusstammzelltransplantation stellt eine der größten Herausforderungen in der chirurgischen Therapie von Oberflächenerkrankungen dar. Während Patienten mit einseitiger oder partieller Limbusstammzellinsuffizienz (LSI) mit autologen lamellären Limbustransplantaten vom Partnerauge versorgt werden, kann bei fortgeschrittener beidseitiger, aber noch partieller LSI eine Ex-vivo-Expansion autologer Limbusstammzellen auf Amnionmembran durchgeführt werden. Dagegen kann die beidseitige komplette LSI nur durch Transplantation allogenen Limbusgewebes mit großen immunologischen Risiken behandelt werden. Die allogene Limbusstammzelltransplantation wurde in den letzten Jahren durch Kombination mit Mitomycin C und Amnionmembrantransplantation erfolgreich weiterentwickelt. Während grundlagenwissenschaftlich zunächst an einer Transdifferenzierung von Knochenmarksstammzellen zu epithelialen Zellen gearbeitet wurde, gab es zuletzt vielversprechende Ansätze zur Verwendung von Haarfollikelstammzellen als Zellquelle. Die Erforschung der Limbusstammzellnische schließlich führt zu einem besseren Verständnis der natürlichen Wachstumsbedingungen von Limbusstammzellen, ein entscheidender Baustein in der Verbesserung der Ex-vivo-Kultur. The transplantation of limbal stem cells is one of the most challenging surgical approaches in ocular surface reconstruction. Partial and unilateral limbal stem cell insufficiency (LSCI) can be treated by fractionated abrasion or autologous limbal stem cell transplantation from the fellow eye. In cases of advanced bilateral and partial LSCI, ex vivo expansion of limbal stem cells on amniotic membranes or fibrin can be performed but all patients with complete bilateral LSCI must rely on allogenic limbal stem cell transplantation with high immunological risks. Attempts to combine allogenic limbal stem cell transplantation with mitomycin C and amniotic membrane transplantation are promising. In the laboratory, attempts to transdifferentiate bone marrow stem cells into corneal epithelial cells have been without success. Nonetheless, transdifferentiation of hair follicle stem cells into corneal epithelial cells looks promising. In parallel, research on the limbal stem cell niche is ongoing to elucidate the natural environment of limbal stem cells in order to improve ex vivo culture.